| NCT Number | NCT07629518 |
| Lead Sponsor | Douglas Brugge
Collaborators: National Heart, Lung, and Blood Institute (NHLBI) |
| Conditions | Cardiovascular (CV) Risk |
| Enrollment | 66 participants |
| Start Date | 2026-09 |
| Primary Completion | 2028-05 (estimated) |
| Study Completion | 2029-05 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-05 |